Clinical Trials Logo

Clinical Trial Summary

This study is to evaluate the efficacy and safety of SHR0302 in subjects with active non-radiographic axial spondyloarthritis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05324631
Study type Interventional
Source Jiangsu HengRui Medicine Co., Ltd.
Contact Xuan Zhang
Phone (+86)13436522766
Email zxlab@outlook.com
Status Recruiting
Phase Phase 3
Start date August 16, 2022
Completion date December 11, 2024

See also
  Status Clinical Trial Phase
Completed NCT03223012 - Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service
Recruiting NCT05622708 - A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission Phase 4
Active, not recruiting NCT05155098 - 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis
Active, not recruiting NCT04732117 - Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis Phase 3
Recruiting NCT05038189 - Evaluation of Spine Posture, Trunk Position Sense and Gait in Axial Spondyloarthritis Patients N/A
Recruiting NCT05242588 - Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA Phase 2